{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:29:34Z","timestamp":1757622574454,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02906-4","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T05:52:53Z","timestamp":1754459573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methylprednisolone pulse therapy compared with intravenous dexamethasone for severe COVID-19 patients: a randomized clinical trial"],"prefix":"10.1186","volume":"22","author":[{"given":"Kaveh","family":"Haratian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arsalan","family":"Alaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Golbarg","family":"Mehrpoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid Kohandel","family":"Gargari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"1","key":"2906_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3325\/cmj.2023.64.13","volume":"64","author":"M Lucijani\u0107","year":"2023","unstructured":"Lucijani\u0107 M, et al. The performance of the WHO COVID-19 severity classification, COVID-GRAM, VACO index, 4\u00a0C mortality, and CURB-65 prognostic scores in hospitalized COVID-19 patients: data on 4014 patients from a tertiary center registry. Croat Med J. 2023;64(1):13\u201320.","journal-title":"Croat Med J"},{"key":"2906_CR2","unstructured":"Cascella M et al. Features, Evaluation, and Treatment of Coronavirus (COVID-19), in StatPearls. 2025, StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.: Treasure Island (FL)."},{"key":"2906_CR3","volume-title":"Clinical management of COVID-19: interim guidance, 27 May 2020","author":"O World Health","year":"2020","unstructured":"World Health O. Clinical management of COVID-19: interim guidance, 27 May 2020. World Health Organization: geneva; 2020."},{"issue":"1","key":"2906_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s13054-020-03400-9","volume":"24","author":"J van Paassen","year":"2020","unstructured":"van Paassen J, et al. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Crit Care. 2020;24(1):696.","journal-title":"Crit Care"},{"issue":"10223","key":"2906_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, et al. Clinical features of patients infected with 2019 novel coronavirus in wuhan, China. Lancet. 2020;395(10223):497\u2013506.","journal-title":"Lancet"},{"issue":"20","key":"2906_CR6","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1001\/jama.2020.6775","volume":"323","author":"S Richardson","year":"2020","unstructured":"Richardson S, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the new York City area. JAMA. 2020;323(20):2052\u20139.","journal-title":"JAMA"},{"issue":"4","key":"2906_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420\u20132.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"2906_CR8","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620\u20139.","journal-title":"J Clin Invest"},{"key":"2906_CR9","doi-asserted-by":"publisher","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","volume":"214","author":"W Zhang","year":"2020","unstructured":"Zhang W, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393.","journal-title":"Clin Immunol"},{"issue":"1","key":"2906_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41392-020-0158-2","volume":"5","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. A retrospective cohort study of Methylprednisolone therapy in severe patients with COVID-19 pneumonia. Signal Transduct Target Ther. 2020;5(1):57.","journal-title":"Signal Transduct Target Ther"},{"issue":"27","key":"2906_CR11","doi-asserted-by":"publisher","first-page":"E756","DOI":"10.1503\/cmaj.200645","volume":"192","author":"Z Ye","year":"2020","unstructured":"Ye Z, et al. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis. CMAJ. 2020;192(27):E756\u201367.","journal-title":"CMAJ"},{"issue":"8","key":"2906_CR12","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Horby P, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704.","journal-title":"N Engl J Med"},{"key":"2906_CR13","unstructured":"Organiztion WH. Corticosteroids for COVID-19. 2020; Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Corticosteroids-2020.1"},{"issue":"1","key":"2906_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(1):18.","journal-title":"BMC Med"},{"key":"2906_CR15","doi-asserted-by":"crossref","unstructured":"Kim S et al. 795: Methylprednisolone compared to dexamethasone for the treatment of hospitalized COVID-19 Patients. Crit Care Med, 2023. 51(1).","DOI":"10.1097\/01.ccm.0000908908.83817.c1"},{"key":"2906_CR16","doi-asserted-by":"crossref","unstructured":"Bajaj D et al. Dexamethasone versus Methylprednisolone in hospitalized COVID-19 patients: a systematic review and Meta-Analysis. Int J Crit Care Emerg Med, 2021. 7.","DOI":"10.23937\/2474-3674\/1510128"},{"issue":"3","key":"2906_CR17","first-page":"e55725","volume":"16","author":"P Kovacevic","year":"2024","unstructured":"Kovacevic P, et al. Comparative efficacy of High-Dose dexamethasone versus Methylprednisolone in coronavirus disease 2019 (COVID-19)-Associated acute respiratory distress syndrome. Cureus. 2024;16(3):e55725.","journal-title":"Cureus"},{"issue":"5","key":"2906_CR18","doi-asserted-by":"publisher","first-page":"e0252057","DOI":"10.1371\/journal.pone.0252057","volume":"16","author":"MA Pinz\u00f3n","year":"2021","unstructured":"Pinz\u00f3n MA, et al. Dexamethasone vs Methylprednisolone high dose for Covid-19 pneumonia. PLoS ONE. 2021;16(5):e0252057.","journal-title":"PLoS ONE"},{"issue":"6","key":"2906_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1177\/0885066621994057","volume":"36","author":"JJ Ko","year":"2021","unstructured":"Ko JJ, et al. A comparison of Methylprednisolone and dexamethasone in intensive care patients with COVID-19. J Intensive Care Med. 2021;36(6):673\u201380.","journal-title":"J Intensive Care Med"},{"key":"2906_CR20","doi-asserted-by":"crossref","unstructured":"Edalatifard M et al. Intravenous Methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial. Eur Respir J, 2020; 56(6).","DOI":"10.1183\/13993003.02808-2020"},{"issue":"2","key":"2906_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/j.jvca.2020.11.057","volume":"35","author":"L Pasin","year":"2021","unstructured":"Pasin L, et al. Corticosteroids for patients with coronavirus disease 2019 (COVID-19) with different disease severity: a Meta-Analysis of randomized clinical trials. J Cardiothorac Vasc Anesth. 2021;35(2):578\u201384.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2906_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.amsu.2020.11.027","volume":"60","author":"SA Fatima","year":"2020","unstructured":"Fatima SA, et al. Comparison of efficacy of dexamethasone and Methylprednisolone in moderate to severe Covid 19 disease. Ann Med Surg (Lond). 2020;60:413\u20136.","journal-title":"Ann Med Surg (Lond)"},{"key":"2906_CR23","doi-asserted-by":"crossref","unstructured":"Ramamoorthy S, Cidlowski JA. Corticosteroids: Mechanisms of action in health and disease. Rheum Dis Clin North Am, 2016. 42(1): pp. 15\u201331, vii.","DOI":"10.1016\/j.rdc.2015.08.002"},{"key":"2906_CR24","doi-asserted-by":"crossref","unstructured":"Wagener F et al. Targeting the heme-heme oxygenase system to prevent severe complications following COVID-19 infections. Antioxid (Basel), 2020. 9(6).","DOI":"10.3390\/antiox9060540"},{"issue":"1","key":"2906_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s41232-022-00253-3","volume":"43","author":"Y Tanaka","year":"2023","unstructured":"Tanaka Y. A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia. Inflamm Regeneration. 2023;43(1):3.","journal-title":"Inflamm Regeneration"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02906-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02906-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T21:04:37Z","timestamp":1757365477000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02906-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2906"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02906-4","relation":{},"ISSN":["1743-422X"],"issn-type":[{"type":"electronic","value":"1743-422X"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The written consent was obtained from each participant. Alborz University of Medical Sciences Ethics Committee (Karaj, Iran) approved this study protocol. Written informed consent was obtained from the patients for participating in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}